Table 4.
K1-70™ dose | Sex | TSH (μIU/mL) | T3 (nmol/L) | T4 (nmol/L) |
---|---|---|---|---|
Mean ± SD | Mean ± SD | Mean ± SD | ||
Control | M | 0.39 ± 0.28 | < 0.50a | 55 ± 7.9 |
F | 0.18 ± 0.16 | 0.58 ± 0.09 | < 33a | |
15 mg/kg/dose (IV) | M | 40.36 ± 7.78 | < 0.46a | < 26a |
F | 35.21 ± 5.38 | < 0.46a | < 26a | |
50 mg/kg/dose (IV) | M | 39.06 ± 6.65 | < 0.46a | < 26a |
F | 39.62 ± 5.91 | < 0.46a | < 26a | |
150 mg/kg/dose (IV) | M | 36.41 ± 8.83 | < 0.46a | < 26a |
F | 33.23 ± 10.91 | < 0.46a | < 26a | |
2 mg/dose (IM) | M | 37.41 ± 14.42 | < 0.46a | < 30a |
F | 31.78 ± 13.32 | < 0.46a | < 26a |
Mean is of n = 10 animals per group per sex. One out of 10 rats injected IM with 2 mg doses of K1-70™ showed normal control levels of TSH 0.43 μIU/mL but T3 and T4 levels below the limit of detection and was not included in the TSH range value. Total T3 levels in the serum were measured using the Siemens Centaur immunoassay system, and Total T4 and TSH levels were measured using Siemens Immulite system
M male, F female
aThe concentration is below the detection limit